Phase 2 Study of Neoadjuvant FGFR Inhibition and Androgen Deprivation Therapy Prior to Prostatectomy.

Saved in:
Bibliographic Details
Title: Phase 2 Study of Neoadjuvant FGFR Inhibition and Androgen Deprivation Therapy Prior to Prostatectomy.
Authors: Liow E; Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia; Department of Medical Oncology, Monash Health, Melbourne, VIC, Australia., Howard N; Urology Unit, Royal Melbourne Hospital, Parkville, VIC, Australia., Jung CH; Melbourne Bioinformatics, The University of Melbourne, Parkville, VIC, Australia., Pope B; Melbourne Bioinformatics, The University of Melbourne, Parkville, VIC, Australia; Department of Medicine, School of Clinical Sciences, Monash University, VIC, Australia; Department of Surgery, University of Melbourne, Royal Melbourne Hospital, VIC, Australia., Campbell BK; Department of Surgery, University of Melbourne, Royal Melbourne Hospital, VIC, Australia., Nguyen A; Department of Surgery, University of Melbourne, Royal Melbourne Hospital, VIC, Australia., Kerger M; Department of Surgery, University of Melbourne, Royal Melbourne Hospital, VIC, Australia; Australian Prostate Centre, North Melbourne, VIC, Australia., Ruddle JB; Department of Surgery, University of Melbourne, Royal Melbourne Hospital, VIC, Australia., Anton A; Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia; Department of Medical Oncology, Monash Health, Melbourne, VIC, Australia., Thomas B; Urology Unit, Royal Melbourne Hospital, Parkville, VIC, Australia; Department of Surgery, University of Melbourne, Royal Melbourne Hospital, VIC, Australia., Chu K; Department of Urology, Monash Health, Melbourne, VIC, Australia., Dundee P; Urology Unit, Royal Melbourne Hospital, Parkville, VIC, Australia., Peters JS; Urology Unit, Royal Melbourne Hospital, Parkville, VIC, Australia., Costello AJ; Urology Unit, Royal Melbourne Hospital, Parkville, VIC, Australia; Department of Surgery, University of Melbourne, Royal Melbourne Hospital, VIC, Australia; Australian Prostate Centre, North Melbourne, VIC, Australia., Ryan AS; TissuPath, Mount Waverley, VIC, Australia., Hovens CM; Department of Surgery, University of Melbourne, Royal Melbourne Hospital, VIC, Australia; Victorian Comprehensive Cancer Centre, Parkville, VIC, Australia., Tran B; Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia., Corcoran NM; Urology Unit, Royal Melbourne Hospital, Parkville, VIC, Australia; Department of Surgery, University of Melbourne, Royal Melbourne Hospital, VIC, Australia; Victorian Comprehensive Cancer Centre, Parkville, VIC, Australia. Electronic address: niallmcorcoran@gmail.com.
Source: Clinical genitourinary cancer [Clin Genitourin Cancer] 2022 Oct; Vol. 20 (5), pp. 452-458. Date of Electronic Publication: 2022 May 18.
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101260955 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0682 (Electronic) Linking ISSN: 15587673 NLM ISO Abbreviation: Clin Genitourin Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1938-0682
DOI:10.1016/j.clgc.2022.05.007